185 related articles for article (PubMed ID: 28125593)
1. Mind the Gap: Gaps in Antidepressant Treatment, Treatment Adjustments, and Outcomes among Patients in Routine HIV Care in a Multisite U.S. Clinical Cohort.
Cholera R; Pence BW; Bengtson AM; Crane HM; Christopoulos K; Cole SR; Fredericksen R; Gaynes BN; Heine A; Mathews WC; Mimiaga MJ; Moore R; Napravnik S; O'Clerigh C; Safren S; Mugavero MJ
PLoS One; 2017; 12(1):e0166435. PubMed ID: 28125593
[TBL] [Abstract][Full Text] [Related]
2. Disparities in Depressive Symptoms and Antidepressant Treatment by Gender and Race/Ethnicity among People Living with HIV in the United States.
Bengtson AM; Pence BW; Crane HM; Christopoulos K; Fredericksen RJ; Gaynes BN; Heine A; Mathews WC; Moore R; Napravnik S; Safren S; Mugavero MJ
PLoS One; 2016; 11(8):e0160738. PubMed ID: 27513328
[TBL] [Abstract][Full Text] [Related]
3. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
4. The Depression Treatment Cascade: Disparities by Alcohol Use, Drug Use, and Panic Symptoms Among Patients in Routine HIV Care in the United States.
DiPrete BL; Pence BW; Bengtson AM; Moore RD; Grelotti DJ; O'Cleirigh C; Modi R; Gaynes BN
AIDS Behav; 2019 Mar; 23(3):592-601. PubMed ID: 30288684
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants for people with epilepsy and depression.
Maguire MJ; Weston J; Singh J; Marson AG
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
[TBL] [Abstract][Full Text] [Related]
6. The impact of an integrated depression and HIV treatment program on mental health and HIV care outcomes among people newly initiating antiretroviral therapy in Malawi.
Stockton MA; Udedi M; Kulisewa K; Hosseinipour MC; Gaynes BN; Mphonda SM; Maselko J; Pettifor AE; Verhey R; Chibanda D; Lapidos-Salaiz I; Pence BW
PLoS One; 2020; 15(5):e0231872. PubMed ID: 32374724
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of dual vs. single-action antidepressants on HIV clinical outcomes in HIV-infected people with depression.
Mills JC; Harman JS; Cook RL; Marlow NM; Harle CA; Duncan RP; Gaynes BN; Pence BW
AIDS; 2017 Nov; 31(18):2515-2524. PubMed ID: 28832409
[TBL] [Abstract][Full Text] [Related]
8. The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial.
Pence BW; Gaynes BN; Adams JL; Thielman NM; Heine AD; Mugavero MJ; McGuinness T; Raper JL; Willig JH; Shirey KG; Ogle M; Turner EL; Quinlivan EB
AIDS; 2015 Sep; 29(15):1975-86. PubMed ID: 26134881
[TBL] [Abstract][Full Text] [Related]
9. Predictors of depression recovery in HIV-infected individuals managed through measurement-based care in infectious disease clinics.
Sowa NA; Bengtson A; Gaynes BN; Pence BW
J Affect Disord; 2016 Mar; 192():153-61. PubMed ID: 26724694
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
[TBL] [Abstract][Full Text] [Related]
11. Psychological therapies for treatment-resistant depression in adults.
Ijaz S; Davies P; Williams CJ; Kessler D; Lewis G; Wiles N
Cochrane Database Syst Rev; 2018 May; 5(5):CD010558. PubMed ID: 29761488
[TBL] [Abstract][Full Text] [Related]
12. Antidepressants for depression in adults with HIV infection.
Eshun-Wilson I; Siegfried N; Akena DH; Stein DJ; Obuku EA; Joska JA
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD008525. PubMed ID: 29355886
[TBL] [Abstract][Full Text] [Related]
13. A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV.
Tsai AC; Weiser SD; Petersen ML; Ragland K; Kushel MB; Bangsberg DR
Arch Gen Psychiatry; 2010 Dec; 67(12):1282-90. PubMed ID: 21135328
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant treatment and health services utilization among HIV-infected medicaid patients diagnosed with depression.
Sambamoorthi U; Walkup J; Olfson M; Crystal S
J Gen Intern Med; 2000 May; 15(5):311-20. PubMed ID: 10840266
[TBL] [Abstract][Full Text] [Related]
15. Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users.
Turner BJ; Laine C; Cosler L; Hauck WW
J Gen Intern Med; 2003 Apr; 18(4):248-57. PubMed ID: 12709091
[TBL] [Abstract][Full Text] [Related]
16. Assessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC Study.
Pence BW; Gaynes BN; Williams Q; Modi R; Adams J; Quinlivan EB; Heine A; Thielman N; Mugavero MJ
Contemp Clin Trials; 2012 Jul; 33(4):828-38. PubMed ID: 22542960
[TBL] [Abstract][Full Text] [Related]
17. Changes in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon.
Gaynes BN; Pence BW; Atashili J; O'Donnell JK; Njamnshi AK; Tabenyang ME; Arrey CK; Whetten R; Whetten K; Ndumbe P
PLoS One; 2015; 10(10):e0140001. PubMed ID: 26469186
[TBL] [Abstract][Full Text] [Related]
18. Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon.
Pence BW; Gaynes BN; Atashili J; O'Donnell JK; Kats D; Whetten K; Njamnshi AK; Mbu T; Kefie C; Asanji S; Ndumbe P
AIDS Behav; 2014 Jun; 18(6):1142-51. PubMed ID: 24558099
[TBL] [Abstract][Full Text] [Related]
19. Time to depression treatment in primary care among HIV-infected and uninfected veterans.
Hooshyar D; Goulet J; Chwastiak L; Crystal S; Gibert C; Mattocks K; Rimland D; Rodriguez-Barradas M; Justice AC;
J Gen Intern Med; 2010 Jul; 25(7):656-62. PubMed ID: 20405335
[TBL] [Abstract][Full Text] [Related]
20. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
